Unimed Technologies Limited.
About Unimed Technologies Limited.
Data last updated:
Unimed Technologies Limited. is a public limited company based in Vadodara, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1997PLC031523. Its GSTIN is 19AAACE4022B1ZB (West Bengal). The company holds 48 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.3 Lakh. It was formerly known as Equity Pharma Private Limited. and Milmet Pharma Private Limited. It is led by directors including Kulvir Nilkanth Kadwadkar and Kailash Sankhlecha.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Synergy House No. 1, Subhanpura Road Vadodara, Gujarat, India – 390003.
As per the financials filed for FY 2025, the company reported a revenue of ₹107.74 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹14.13 Cr (net margin 13.1%) and EBITDA of ₹46.24 Cr (EBITDA margin 42.9%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 15% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Cr and satisfied charges of ₹130 Cr on record. Court records list 37 cases involving the company, including 27 filed by the company and 10 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor Synergy House No. 1, Subhanpura Road Vadodara, Gujarat, India – 390003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Unimed Technologies Limited.
The main business activity of Unimed Technologies Limited is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Unimed Technologies Limited. FY 2025 filings available
Unimed Technologies Limited. reported revenue of ₹107.74 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Unimed Technologies Limited.
Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 15%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Unimed Technologies Limited.
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹46.24 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.13 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Unimed Technologies Limited.
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 42.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 13.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unimed Technologies Limited are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Unimed Technologies Limited.
Unimed Technologies Limited. is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novus Life Sciences Private Limited | ₹109.09 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Mumbi, Maharashtra, India |
| Chemtech Intermediates Limited | ₹109 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Vadodara, Gujarat, India |
| Quest Laboratories Limited | ₹108.21 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Dhar, Madhya Pradesh, India |
| Meyonex Pharmaceuticals Limited | ₹108.15 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Palghar, Maharashtra, India |
| Shiva Biogenetic Pharmaceuticals Private Limited | ₹107.81 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Solan, Himachal Pradesh, India |
| Unimed Technologies Limited. this company | ₹107.74 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Shivalik Remedies Private Limited | ₹107.31 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Genetek Lifesciences Private Limited | ₹107.01 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Nagpur, Maharashtra, India |
| Chemo India Formulation Private Limited | ₹106.58 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Hyderabad, Telangana, India |
| Venor Pharma Limited | ₹106.47 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Delhi, India |
| Hi-Tech Formulations Private Limited | ₹105.6 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Unimed Technologies Limited by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Unimed Technologies Limited.
Unimed Technologies Limited. is audited by ASDT & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASDT & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Unimed Technologies Limited.
Unimed Technologies Limited has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kulvir Nilkanth Kadwadkar | Director | 28 Mar 2009 | 17 Years 6 Months | Current |
| Kailash Sankhlecha Also directs: Madhusudan Cybernetic Private Limited | Director | 29 Sep 2009 | 17 Years 0 Months | Current |
| Darshna Devang Mehta | Director | 18 Jan 2016 | 10 Years 8 Months | Current |
Ownership and Shareholding of Unimed Technologies Limited.
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unimed Technologies Limited.
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Apr 2014 | Indusind Bank Ltd. | ₹10 Cr | Open |
| 02 Feb 2015 | Indusind Bank Ltd. | ₹130 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Unimed Technologies Limited.
Unimed Technologies Limited. has 37 court cases on record: 27 filed by Unimed Technologies Limited, 10 filed against it. All cases are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 35 | 8 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Special civil application | Filed by the company against Stratus Foods Private Limited | Disposed |
| District court, Panchmahal at Godhra, Gujarat | Commercial matter | Filed against the company by Stratus Foods Private Limited | Disposed |
| Madras High Court | Original application | Filed by the company against Eye Kare Kilitch Limited | Disposed |
| Madras High Court | Appeal | Filed by the company against Eye Kare Kilitch Limited | Disposed |
| High Court of Gujarat | Appeal | Filed by the company against Hetero Drugs Limited | Disposed |
Full case history
All 37 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Unimed Technologies Limited.
Unimed Technologies Limited. has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 16 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Brite Proofings Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Unimed Technologies Limited.
Unimed Technologies Limited. has a workforce of 4 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Unimed Technologies Limited.
Unimed Technologies Limited has undergone 4 name changes throughout its history. The current legal name is Unimed Technologies Limited..
| Company Name | Status |
|---|---|
| Unimed Technologies Limited. | Current |
| Equity Pharma Private Limited. | Previous |
| Milmet Pharma Private Limited | Previous |
| Equity Pharma Private Limited | Previous |
| Milmet Pharma Limited | Previous |
Recent Activity on Unimed Technologies Limited.
Unimed Technologies Limited. has 10 board changes on record since 2009: 3 appointments and 7 cessations. The latest: Pragnesh Kumar Doshi ceased to be Director on 29 Aug 2018.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Unimed Technologies Limited.
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unimed Technologies Limited.
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Unimed Technologies Limited.
Unimed Technologies Limited has 48 GST registrations: 5 active and 43 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAACE4022B1ZB | West Bengal | Active | 01 Jul 2017 |
| 27AAACE4022B2ZD | Maharashtra | Active | 01 Jul 2017 |
| 29AAACE4022B1ZA | Karnataka | Active | 01 Jul 2017 |
| 33AAACE4022B1ZL | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unimed Technologies Limited.
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unimed Technologies Limited.
Unimed Technologies Limited is an active public limited company based in Vadodara, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 January 1997 (29+ years old) and is registered under CIN U24230GJ1997PLC031523.
Unimed Technologies Limited reported revenue of ₹107.74 Cr for FY 2025 (up 11% YoY).
Unimed Technologies Limited has 3 current directors:
- Kulvir Nilkanth Kadwadkar - Director
- Kailash Sankhlecha - Director
- Darshna Devang Mehta - Director
Unimed Technologies Limited reported a net profit of ₹14.13 Cr (net margin 13.1%) and EBITDA of ₹46.24 Cr (EBITDA margin 42.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Unimed Technologies Limited is 25% over three years and -15% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Unimed Technologies Limited is 19AAACE4022B1ZB, registered in West Bengal. The company has 48 GST registrations in all, of which 5 are active and 43 are cancelled or inactive. Other active GSTINs include 27AAACE4022B2ZD (Maharashtra), 29AAACE4022B1ZA (Karnataka), 33AAACE4022B1ZL (Tamil Nadu).
The CIN (Corporate Identification Number) of Unimed Technologies Limited is U24230GJ1997PLC031523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimed Technologies Limited has 37 court cases on record: 27 filed by the company and 10 filed against it. Most are in the high courts.
Unimed Technologies Limited was incorporated on 17 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Unimed Technologies Limited by revenue are Novus Life Sciences Private Limited, Chemtech Intermediates Limited, Quest Laboratories Limited, Meyonex Pharmaceuticals Limited, Shiva Biogenetic Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Pragnesh Kumar Doshi ceased to be Director on 29 Aug 2018. Sanjay Sharma ceased to be Whole-Time Director on 01 Apr 2017. Darshna Devang Mehta ceased to be Additional Director on 29 Sep 2016. Unimed Technologies Limited has 10 board changes on record in total.
Unimed Technologies Limited has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 16 overdue payments to 2 micro and small suppliers. The latest return was filed on 18 Oct 2021.